Vanderbilt-Ingram website >
Reed Omary, MD, MS, Carol D. and Henry P. Pendergrass Professor and chair of Radiology & Radiological Sciences, is stepping down from his role as the department’s leader.
Research conducted at Vanderbilt points to a new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.
A Vanderbilt study that delved into genetic predisposition for early-onset colorectal cancer by race and ethnicity has identified differing germline risk variants.
Ideas for addressing the disproportionate impact of cancer, diabetes, and gastrointestinal diseases on disadvantaged populations were shared recently during a diversity symposium at Vanderbilt University Medical Center.
The expected course of a patient’s cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence.
Vanderbilt research shows that a liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers.
Accessibility Tools